Kava is rapidly gaining popularity in Australia as consumers seek a healthier alternative to alcohol, according to The Calmer Co's FY2024 Q4 report. The Queensland-based company has seen significant growth in e-commerce, with daily sales exceeding AUD$18.5k (US$12k), marking over 500% growth in the past year. This surge is driven by health-conscious consumers looking to replace alcohol and those seeking supplements to reduce anxiety and support sleep.
The company's flagship brand, FijiKava, offers a range of kava-based products, including powder drinks, teas, and supplements, while its other brands, Taki Mai and Danodan, focus on kava shots and CBD tinctures. Australia is the largest market, contributing 70% of the company's Q4 revenue, which was up 194% year-on-year to AUD$1.8m (US$1.18m). The Calmer Co is also expanding its offline presence, with products now available in 799 Coles stores across Australia.
Looking ahead, The Calmer Co plans to replicate its e-commerce success in the US and expects total sales of at least AUD$4m for FY24. The company also completed an oversubscribed capital raise of AUD$2.65m (US$1.73m) to expand its manufacturing facility in Fiji and increase inventory, aiming to double its processing capacity.
Comments